HUMAN AMYLOID IMAGING CONFERENCE

The 18th edition of the HAI will be held in San Juan, Puerto Rico on January 12-14, 2026.

HAI 2026 POSTER SESSIONS

Click the “+” to open each module; tables can be sorted by clicking on each item of the header row (board number, poster title, authors and presenter, respectively). Additionally, each table is searchable (use the search field located at the top right of each module).

Please note that we reserve the right to re-arrange the poster allocation.

POSTER SESSIONS: 1A - Monday, January 12 - 10:30 am - 11:30 pm; 1B - Monday, January 12, 4:20 - 5:20 pm

Board #	Title	Authors	Presenter
01	Longitudinal harmonization effects on tau-PET SUVRs trajectories in ADNI study	Ren \| Luo \| Laymon \| Minhas \| Cohen \| Wu \| Tudorascu	Ren, Yuxin
02	Integrating digital cognitive metrics with PET biomarkers to identify individuals at imminent risk of tau accumulation	Fu \| Robinson \| Farrell \| Jutten \| Thibault \| Thompson \| Tiss \| Chen \| Becker \| Healy \| Penney \| Davis \| Sperling \| Price \| Rentz \| Johnson	Fu, Jessie Fang-Lu
03	Amyloid-induced neuronal hyperactivity and metabolism are associated with faster tau accumulation in Alzheimer’s Disease	Roemer-Cassiano \| Zhang \| Evangelista \| Klonowski \| Hirsch \| Frontzkowski \| Steward \| Dewenter \| Biel \| Zhu \| Gnoerich \| Jaekel \| Hoeglinger \| Brendel \| Yeo \| Franzmeier	Roemer-Cassiano, Sebastian
04	Sex differences in white matter microstructure and associations with amyloid and tau pathology in autosomal dominant Alzheimer's disease	Giudicessi \| Koops, PhD \| Baena \| Alvarez \| Vidal \| Martinez \| Gonzalez \| Tristão-Pereira \| Malotaux \| He \| Aguillon \| Jacobs \| Cronin-Golomb \| Quiroz	Giudicessi, Averi
05	Concordance between amyloid PET and biomarkers of Alzheimer’s disease in plasma and cerebrospinal fluid in cognitively unimpaired individuals	Bermudez \| Fought \| Hofrenning \| Lowe \| Petersen \| Vemuri \| Jack, Jr. \| Algeciral-Schimnich \| Bornhorst \| Graff-Radford	Bermudez, Camilo
06	Comparing performance of different amyloid PET markers of spatial extent in their ability to predict future amyloid conversion	Honhar \| Farrell \| Properzi \| Thibault \| Schultz \| Becker \| Fu \| Sperling \| Price \| Johnson	Honhar, Praveen
07	Elevated ptau217 is more strongly associated with tau accumulation and cognitive decline in younger adults	Coughlan \| Townsend \| Li \| Seto \| Birkenbihl \| Cody \| Klinger \| Healy \| Farrell \| Thibault \| Rissman \| Properzi \| Schultz \| Chhatwal \| Yang \| Donohue \| Betthauser \| Johnson \| Johnson \| Sperling \| Buckley	Coughlan, Gillian
08	Quantitative relationship between Lumipulse G measures of pTau217 in plasma and in brain	Vandenberghe \| Tomé \| De Meyer \| Goossens \| Lambrechts \| Poesen \| Vanbrabant \| Vanmechelen \| Thal	Vandenberghe, Rik
09	Distinct mechanisms underlying APOE-ε4 and sex effects on medial temporal tau pathology: A neuropathology study	Salvadó \| Groot \| Wisse \| Vogel \| Beach \| Serrano \| Reiman \| Schneider \| Bennett \| Ossenkoppele \| Hansson	Salvadó, Gemma
10	Harmonizing amyloid PET tracers at the regional level: evaluation of regional centiloid equations	Silvestri \| Chaggar \| Gobbi \| Aldea \| Klein \| Tonietto	Tonietto, Matteo
11	A case series of lecanemab treatment response in patients across the clinical phenotypic spectrum of AD	Corriveau-Lecavalier \| Machulda \| Fields \| Boots \| Whitwell \| Day \| Aduen \| Frank \| Kremers \| Ramanan \| Graff-Radford \| Lowe \| Boeve \| Knopman \| Petersen \| Jack \| Stricker \| Jones	Corriveau-Lecavalier, Nick
12	Validation of a pseudo-reference region for [11C]-ER176 in healthy volunteers and Alzheimer’s disease patients	Finn \| Zanotti-Fregonara \| Yu \| Masdeu \| Pascual	Finn, Quentin
13	β-amyloid PET signal reduction is higher in regions with ARIA-E due to anti-amyloid therapy	Finn \| Pascual \| Toledo \| Schulz \| Masdeu	Finn, Quentin
14	Lifetime and 10-year absolute risk of cognitive impairment associated with amyloid PET severity: a retrospective, longitudinal cohort study	Hu \| Therneau \| Wiste \| Knopman \| Vemuri \| Graff-Radford \| Lowe \| Vassilaki \| Cogswell \| Schwarz \| Algeciras-Schimnich \| Petersen \| Jack Jr.	Hu, Mingzhao
15	Trajectory of neurodegeneration and brain aging in relation to amyloid timing and duration	Zhang \| Robb \| Erus \| Castellano \| Cui \| Cody \| Harrison \| Engelman \| Albert \| Resnick \| Sperling \| Bilgel \| Vardarajan \| Mayeux \| Risacher \| Arfanakis \| Tosun \| Habes \| Wang \| Toga \| Thompson \| Kukull \| Biber \| Landman \| Bendlin \| Johnson \| Schneider \| Barnes \| Bennett \| Saykin \| De Jager \| Menon \| Harrison \| Mormino \| Cuccaro \| Davatzikos \| Betthauser \| Archer \| Hohman \| Dumitrescu \| Koran	Zhang, Mengna
16	Associations between tau pathology and cortical microstructure are modulated by amyloid burden independent of cortical atrophy in cognitively unimpaired older adults	Vogt \| Koops \| Schultz \| Properzi \| Salat \| Pascual-Leone \| Huang \| Buckley \| Rentz \| Johnson \| Sperling \| Jacobs	Vogt, Nicholas
17	Predicting tau PET burden using brain-derived plasma p-tau measures in the British 1946 birth cohort	Schott \| Coath \| Wiltshire \| Brown \| Cash \| Whittington \| Heslegrave \| Zetterberg \| Keshavan	Schott, Jonathan
18	Association of combined cardiovascular risk factors and treatments with longitudinal amyloid and tau PET in cognitively normal older adults	Ourry \| Thériault-Dubé \| Breitner \| Poirier \| Villeneuve	Ourry, Valentin
19	Amyloid-pet substantiates clinical decision-making in real-life clinical settings in Brazil	Schaffer Aguzzoli \| Flach \| Alves Da Silva \| C.L Ferreira \| Povala \| Ferrari-Souza \| Bieger \| Teixeira Leffa \| Bellaver \| Guevara Werlang \| Teribele Venturin \| Wetters Portuguez \| Possa Marroni \| Irigoyen da Costa \| Bernardi Soder \| Sebastião Matushita \| Juarez Amorim \| Pasquotto Souza \| Dario Ramos \| Leite \| Hygino \| Amorim Nogueira \| Sturzeneker Tres \| Okada de Oliveira \| Moriguchi Jeckel \| Cortes Domingues \| Mosci \| Rosado de Castro \| Buchpiguel \| Paiva Proença Lobo Lopes \| Carvalho Campos Neto \| Figueiredo Balthazar \| Tovar Moll \| Martins Novaes Coutinho \| Pascoal \| Zimmer \| Schilling \| Costa da Costa	Schaffer Aguzzoli, Cristiano
20	Neuropathological validation of Tau-PET CenTauR units: Preliminary data from a multicenter study	Iaccarino \| Chiotis \| Grinberg \| Kotari \| La Joie \| Leuzy \| Lowe \| Lu \| Moscoso \| Nguyen \| Schwarz \| Seeley \| Jack \| Rabinovici \| Shcherbinin	La Joie, Renaud
21	Molecular evaluation of a tau-PET analog and pathological TAR DNA-binding protein 43 docking in a cellular model of frontotemporal lobar degeneration	Gatto \| Weissmann \| Salinas Castellanos \| Montes \| Uruk \| Youssef \| Reichard \| Josephs	Gatto, Rodolfo G.
22	Anterior cingulate sulcal pattern is associated with successful cognitive aging	Maboudian \| Kellerman \| Willbrand \| Pezzoli \| Weiner \| Jagust	Maboudian, Samira
23	Microstructural white matter injury mediates the association between vascular risk and plasma biomarkers: Preliminary findings from the Diverse VCID study	Lee \| Sapkota \| Rajan \| Jin \| Hinman \| Johnson \| Harvey \| Maillard \| Fornage \| DeCarli	Lee, Seunghoon
24	VeraBIND Tau: a novel plasma assay reflecting tau aggregation increases over time in individuals with positive tau-PET signal	Hanseeuw \| Quenon \| Bayart \| Salman \| Pak \| Shamsundar \| Soldo \| Iqbal	Hanseeuw, Bernard
25	Amyloid PET quantitation using skewness: Autopsy validation and test–retest performance	Tunali \| Iaccarino \| Wang \| Kennedy \| Lu \| Shcherbinin	Tunali, Ilke
26	Stratifying preclinical Alzheimer’s disease by hippocampal volume to detect concomitant LATE	Mundada \| Lyu \| Sadeghpour \| Brown \| McGrew \| Yushkevich \| Das \| Wolk	Mundada, Nidhi
27	Differential sensitivity of [¹⁸F]MK6240 and [¹⁸F]FTP to measure tau before and after anti-amyloid therapy	Deng \| Finn \| Pando \| Matutue \| Lussier \| Fortea \| Tudorascu \| Soleimani-Meigooni \| Lowe \| Oh \| Gordon \| Rosa-Neto \| Baker \| Pascoal \| Masdeu \| Pascual	Deng, Han
28	Development of a highly sensitive and automated immunoassay for Brain-Derived pTau-217: Analytical performance in human plasma samples	Ma \| Wang \| Danthanarayana \| Kim \| Ji \| Jhaveri \| Zhang \| Qiu \| Mudumba \| Luo	Ma, Xiao-Jun
29	Network-based mechanistic modeling of Alzheimer's disease for evaluating diverse therapeutic mechanisms of action	Wooten \| Stage \| Mazer \| Townsend \| Comley \| Guo	Wooten, Dustin
30	Neuroimaging compendium of microglia, amyloid, tau, and neurodegeneration across clinical variants of Alzheimer's disease	Houlihan \| Guzman \| Smith \| Sanchez \| Kreisl \| Cosentino \| Noble \| Lao	Houlihan, Hannah
31	Predictors of longitudinal atrophy across NIA-AA biological PET stages	Fonseca \| Maboudian \| Chao \| Jagust \| Harrison	Fonseca, Corrina
32	Effect of uptake time on [18F]-flutemetamol visual interpretation and Centiloid quantification	Bollack \| Buckley \| Schwarz \| Battle \| Smith \| Stromrud \| Hansson \| Palmqvist \| Matttsson-Carlgren \| La Joie \| Farrar	Bollack, Ariane
33	Episodic memory decline and tau biomarkers progress earlier along the amyloid timeline in Down syndrome compared to neurotypical adults	Zammit \| Bruzzone \| Morse \| Batchelar \| Bettcher \| McLachlan \| McVea \| Carey \| Tudorascu \| Hartley \| Clark \| Ances \| Caldwell \| Johnson \| Handen \| Head \| Mapstone \| Christian \| Investigators \| Betthauser	Zammit, Matt
34	Relationship between p-tau217 and PET in preclinical AD: The moderating effect of white matter hyperintensity	Moon \| Chen	Moon, Hasom
35	Systemic inflammation–tau interaction: Insights from CRP modulation of p-tau217 association with tau PET positivity	Monto \| Boots \| Zeng \| Farinas \| Sehrawat \| Saeed \| Cohen \| Reis \| Lopez \| Snitz \| Karikari	Monto, Abdul Razak
36	Examining elevated choroid plexus binding of tau PET tracers in aging and Alzheimer’s disease	Marin \| Wales \| Ruais \| Richard \| Hedden	Marin, Anna
37	The influence of β-amyloid on neuroinflammatory 11C-ER176 uptake in progressive apraxia of speech	Satoh \| Utianski \| Duffy \| Clark \| Botha \| Lowe \| Josephs \| Whitwell	Satoh, Ryota
38	Subtracting first principal component may improve detectability of subtle 4R tau signals in 18F flortaucipir tau PET imaging	Satoh \| Ali \| Clark \| Dickson \| Lowe \| Josephs \| Whitwell	Satoh, Ryota
39	OMG: a proteomic determinant of neurodegenerative resiliency	Duggan \| Oh \| Frank \| Gomez \| Zweibaum \| Cui \| Chen \| Surapaneni \| Blew \| Dark \| Joynes \| Kandala \| Bilgel \| Farinas \| Erus \| Tian \| Candia \| Pucha \| Landman \| Dumitrescu \| Hohman \| Lewis \| Moghekar \| Siavoshi \| Ali \| Liu \| Xu \| Western \| Kaneko \| Kato \| Furuichi \| Shibayama \| Katsuno \| Nishita \| Otsuka \| Gottesman \| Dammer \| Seyfried \| Levey \| Johnson \| Mormino \| Wagner \| Poston \| Kapogiannis \| Grams \| Bhargava \| Waga \| Davatzikos \| Resnick \| Ferrucci \| Bennett \| Cruchaga \| Wyss-Coray \| Kivimäki \| Coresh \| Walker	Duggan, Michael
40	Frequency and consequences of extreme PET based pathological profiles in preclinical Alzheimer’s disease	Medina Guerra \| Cody \| Young \| Sheng \| Sokolowski \| Younes \| Trelle \| Tosun \| Hohman \| Mormino	Medina Guerra, Lucah
41	Periventricular diffusivity moderates the relationship between astrocyte reactivity and amyloid deposition in non-demented older adults	Chen \| Wu \| Yang \| Gogola \| Luo \| Villemagne \| Laymon \| Lopresti \| Cohen \| Ikonomovic \| Snitz \| Wilckens \| Lopez \| Tudorascu \| Aizenstein \| Minhas	Chen, Chang-Le
42	Disentangling the effects of age and Alzheimer's disease pathology on longitudinal atrophy in cognitively normal older adults	Haque \| Fonseca \| Maboudian \| La Joie \| Jagust	Haque, Miraal
43	Stronger amyloid–tau coupling explains faster tau progression in early-onset Alzheimer’s disease	Franzmeier \| Frontzkowski \| Steward \| Klonowski \| Dewenter \| Hirsch \| Biel \| Zhu \| Gnörich \| Höglinger \| Brendel \| Roemer-Cassiano	Franzmeier, Nicolai
44	Harmonization methods to mitigate batch effects in blood biomarker analysis	Zhang \| Lukasewicz Ferreira \| Minhas \| Pascoal \| Zeng \| Karikari \| Cohen \| Tudorascu	Zhang, Vivian
45	IGFR1, but not BDNF, acts as a suppressive neuroprotective factor between astrogliosis and visuospatial function among non-demented individuals	Ramirez Tirado \| Cohen \| Lopresti \| Ikonomovic \| Gogola \| Matan \| Zeng \| Karikari \| Lopez \| Shaaban \| Villemagne	Cohen, Ann D
46	The relation of psychosocial coping mechanisms to ATN pathophysiology differ across demographics	Schatz \| Snitz \| Roush \| Lopresti \| Villemagne \| Lopez \| Williams \| Cohen	Cohen, Ann
47	Evaluation of the Clinical IMpact of Blood-Based Biomarker Assays on dementia specialists' decision-making (CIMBBBA): Preliminary report from a real-world dementia subspecialty clinic study	Eldaief \| Krahn \| Murdock \| Rezaii \| Chan \| Arnold \| Avetisyan \| Ramirez Gomez \| Gale \| McGinnis \| Dickerson	Eldaief, Mark
48	Dynamic interplay of vascular injury and inflammation on Alzheimer’s disease pathophysiology	Rusdi \| Kang \| Yin \| Gibson \| Rahmouni \| Benedet \| Zetterberg \| Blennow \| Karikari \| Ashton \| Black \| Rosa-Neto \| Goubran \| Ottoy	Ottoy, Julie

POSTER SESSIONS: 2A - Tuesday, January 13 - 09:50 - 10:50 am; 2B - Tuesday, January 13, 3:40 - 4:40 pm

Board #	Title	Authors	Presenter
49	CSF oligodendrocyte biomarkers are associated with amyloid burden in Alzheimer’s disease	Santos Machado \| De Bastiani \| Lebrun \| Povala \| Pola \| Vizlin-Hodzic \| Rosa-Neto \| Zimmer \| Blennow \| Zetterberg \| Benedet \| Ashton	Santos Machado, Luiza
50	Associations between systolic blood pressure and amyloid burden on cross-sectional inferior temporal tau across mid- to late-life	Yau \| Scott \| Palmgren \| Coughlan \| Kirn \| Properzi \| Schultz \| Ghosh \| Buckley \| Amariglio \| Rentz \| Johnson \| Sperling \| Beiser \| Seshadri \| Chhatwal	Yau, Wai-Ying Wendy
51	Associations of ER176 TSPO PET with blood-based AD and neuroinflammation biomarkers	Cogswell \| Lundt \| Ou \| Algeciras-Schimnich \| Zekeridou \| Lim \| Graff-Radford \| Schwarz \| Vemuri \| Petersen \| Jack Jr \| Lowe	Cogswell, Petrice
52	Evaluation of [18F]MK6240 test-retest reproducibility for different processing pipelines	Tiss \| Thibault \| Fu \| Becker \| Price \| Johnson	Tiss, Amal
53	Temporal dynamics of tau PET subtypes and its association with heterogeneous neurodegeneration in Alzheimer’s disease	Kwon \| Song \| Lee \| Seong	Kwon, Tae Youn
54	A-T-N-C generative model for predicting and simulating patient-tailored cognitive decline trajectories in Alzheimer’s disease	Lee \| Song \| Kwon \| Lee \| Seong	Kwon, Tae Youn
55	High-resolution ex-vivo MRI reveals layer-specific atrophy of hippocampal subregions to earliest tau pathology	Salman \| Tomé \| Joudiou \| Thal \| Annettesdotter \| Khandelwal \| Yushkevich \| Gallez \| Wisse \| Hanseeuw	Salman, Yasmine
56	Blood volume influences the association between baseline plasma biomarker values and amyloid PET outcomes over time	Burns \| Gogola \| Zeng \| Karikari \| Jacobs \| Lopresti \| Osorio	Burns, Kelsey
57	Visual interpretation methods for tau-PET imaging with Flortaucipir and MK-6240: Insights from the HEAD study	Ruppert \| Vermeiren \| Scop Medeiros \| Povala \| Rocha \| Soares \| Ferreira \| Amaral \| Bauer-Negrini \| Lussier \| Scarpatto Rodrigues \| Oliveira Jr. \| Mroue \| Bellaver \| Moscoso \| Ossenkoppele \| van de Giessen \| Masdeu \| Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Pascoal, Tharick
58	Associations between TSPO PET and CSF and blood-based biomarkers	Smith \| Guzman \| Houlihan \| Sanchez \| Kreisl \| Talmasov \| De Jager \| Herman \| Simoes \| Small \| Lao	Smith, Anna
59	Regional white matter injury modifies the association between ß-amyloid and cognition	Royse \| Reese \| Snitz \| Hengenius \| Crane \| Mukherjee \| Choi \| Willie-Permor \| Felix \| Huppert \| Roush \| Cisneros \| Potopenko \| Lopresti \| Cohen \| Shaaban	Royse, Sarah
60	Sex differences in neuroinflammation, amyloid, tau, and neurodegeneration	Guzman \| Smith \| Houlihan \| Sanchez \| Akinci \| Luchsinger \| Lao	Guzman, Diana
61	Evaluation of the tau PET ligand [18F]florzolotau in frontotemporal dementia	Clarke \| Whittington \| Sholaja \| Hield \| Huiban \| van den Berg \| Margolin \| Rowe \| Rohrer \| Salinas \| Rabiner	Whittington, Alex
62	Intersections of gender/sex and neighborhood deprivation on cognition: Are there mediation effects of Alzheimer's disease biomarkers?	Reese \| Royse \| Snitz \| Crane \| Mukherjee \| Choi \| Hengenius \| Huppert \| Roush \| Cisneros \| Lopresti \| Rameriz Tirado \| Willie-Permor \| Felix \| Cohen \| Shaaban	Reese, Alexandria
63	Disentangling cognitive severity and phenotype across dementia syndromes	Smith \| Coyle-Gilchrist \| Murley \| Rouse \| Stockton \| Naessens \| Savulich \| Wiggins \| Malpetti \| Bowns \| Perquin \| Lanskey \| Karadag \| Kocagoncu \| Quinn \| Pitt \| Alcock \| O'Brien \| Rittman \| Rowe \| Lambon-Ralph	Smith, Viktorija
64	Standardized indices of tau burden using the CenTauR universal scale predict distinct cognitive trajectories across Alzheimer’s disease biological stages	Lopresti \| DelBene \| Leuzy \| Gogola \| Harrison \| Landau \| Jagust \| Villemagne	Lopresti, Brian
65	SPARE-SVD: An integrated machine-learning metric for cerebral small vessel disease within the ATN(V) framework	Dong \| Zhang \| Zeng \| Wang \| Wang \| Toledo \| Gonzales \| Charisis \| Rashid \| Seshadri \| Crane \| Archer \| Jefferson \| Hohman \| Habes	Dong, Mengjin
66	Risk factors and AD prevention: a multivariate and multimodal study	Fajardo Valdez \| Qiu \| Ourry \| Yakoub \| Villeneuve \| Research Group	Fajardo Valdez, Alfonso
67	MK6240 and Tauvid positivity, cognitive decline, and their relationship to Aβ PET deposition across the Alzheimer’s spectrum	Bellaver \| Povala \| Lussier \| Amaral \| Bauer-Negrini \| Ferreira \| Jagust \| Masdeu \| Fortea \| Tudorascu \| Soleimani-Meigooni \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Bellaver, Bruna
68	Differential tau-PET load predominance along shared progression trajectories determines clinical variability in Alzheimer’s disease	Mroué \| Povala \| Bellaver \| Lukasewicz Ferreira \| Bauer-Negrini \| Lussier \| Amaral \| Scop Medeiros \| Ruppert \| Silva da Rocha \| Scarpatto Rodrigues \| Silva Oliveira \| Soares Katz \| Teixeira Leffa \| Saha \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Povala, Guilherme
69	Head-to-head comparison of tau PET tracers across the Alzheimer’s disease spectrum: baseline results from the HEAD study	Povala \| Bellaver \| Lussier \| Amaral \| Bauer-Negrini \| Ferreira \| Jagust \| Masdeu \| Fortea \| Tudorascu \| Soleimani-Meigooni \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Povala, Guilherme
70	Comparison of Sampled Iterative Local Approximation (SILA) implemented in R and MATLAB	Bruzzone \| Coath \| Navaratna \| Carey \| Morse \| Bilgel \| Betthauser	Bruzzone, Hailey
71	Agreement between amyloid status prediction from visual read, SUVR thresholding, and AI-based interpretation of amyloid PET	Peraza \| Joules \| Mohs \| Beauregard \| Dwyer \| Hughes \| Wolz	Wolz, Robin
72	CenTauR thresholds generated using Gaussian Mixture Models for biological staging of amyloid positive ADNI participants	DelBene \| Villemagne \| Gogola \| Leuzy \| Harrison \| Landau \| Jagust \| Lopresti	DelBene, Alexander
73	Progression to tau-PET positivity by plasma P-tau217 levels and its association with clinical decline in preclinical Alzheimer’s disease: data from A4 study	Kim \| Kotari \| Morris \| Shcherbinin \| Yaari \| Holdridge \| Sims \| Ossenkoppele \| Collins \| Hansson \| Lu	Kim, Min Jung
74	Neuroimaging correlates of loneliness	Sanchez \| Guzman \| Smith \| Houlihan \| Stern \| Bockting \| Lao	Sanchez, Thairi
75	Age-dependent associations between salivary inflammatory cytokines and amyloid-beta in cognitively unimpaired older adults	Parker \| Tang \| Taylor \| Bock \| Meza \| Tuteja \| Avila \| Chang \| Simmons \| Bamford \| Yi \| Mcmillan \| Kim \| Thomas \| Adams \| Yassa	Parker, Dana
76	Tau accumulation drives worsening depressive symptoms in cognitively normal older adults	Markova \| Berry	Markova, Teodora
77	Dorsal raphe nucleus and locus coeruleus differentially relate to depressive symptoms in cognitively normal older adults	Markova \| Chen \| Carlson \| Cao \| Ciampa \| Marcus \| Adornato \| Matulonis \| Morin \| Hooker \| Berry	Markova, Teodora
78	Evaluating occipital-to-global amyloid PET as a predictor of CAA at autopsy in Mayo Clinic cohorts	Schwarz \| Hu \| Cogswell \| Graff-Radford \| Vemuri \| Przybelski \| Wiste \| Nguyen \| Reichard \| Dickson \| Lowe \| Ramanan \| Knopman \| Petersen \| Jack	Schwarz, Christopher
79	SCAN: Standardized Centralized Alzheimer’s and related dementias Neuroimaging	Schwarz \| Harrison \| DeCarli \| Kantarci \| Baker \| La Joie \| Maillard \| Rabinovici \| Toga \| Jack \| Jagust	Schwarz, Christopher
80	Differential contributions of amyloid spatial extent and tau burden to domain-specific cognitive decline in early Alzheimer’s disease	Slade \| Thibault \| Thompson \| Fanglu Fu \| Price \| Rentz \| Sperling \| Johnson \| Farrell	Slade, Elliott
81	PET-measured amyloid accumulation rate modulates tau accumulation rate in individuals with Down syndrome	Bettcher \| McLachlan \| Zammit \| McVea \| Betthauser \| Laymon \| Tudorascu \| Cohen \| Price \| Head \| Mapstone \| Lao \| Johnson \| Ances \| Handen \| Christian	Bettcher, Brecca
82	Elevated medial temporal lobe tau predicts cross-sectional association between neocortical tau and global amyloid burden	Thibault \| Reilhac-Laborde \| Charil \| Irizarry \| Johnson	Thibault, Emma G.
83	Assessing the effect of amyloid status on the relationship between glucose metabolism and synaptic density in the aging population	McLachlan \| Bettcher \| DiFilippo \| LeMerise \| McVea \| Zammit \| Langhough \| Johnson \| Bendlin \| Christian	McLachlan, Max
84	Associations between p-tau217 and brain atrophy are amplified by Aβ burden and APOEε4	Brown \| Properzi \| Cuppels \| Birkenbihl \| Coughlin \| Seto \| Townsend \| Betthauser \| Schultz \| Chhatwal \| Yang \| Jacobs \| Farrell \| Johnson \| Johnson \| Li \| Sperling \| Hohman \| Donohue \| Buckley	Brown, Jane
85	Early cortical thickness change in preclinical AD development	Sinclair \| Chen	Sinclair, Stephanie
86	Immuno-vascular crosstalk drives tau pathology preferentially in women	Wood Alexander \| Kang \| Rusdi \| Yin \| Rahmouni \| Wang \| Benedet \| Zetterberg \| Blennow \| Karikari \| Ashton \| Black \| Goubran \| Rabin \| Ottoy	Wood Alexander, Madeline
87	Midlife physical activity attenuates the association of earlier menopause with tau pathology and cognitive decline	Wood Alexander \| Cadwallader \| Johnson \| Casaletto \| Rabin	Wood Alexander, Madeline
88	Improved tau PET signal detection with total-body PET compared to conventional PET: A preliminary study	Young \| Bayerlein \| Bhattarai \| DeCarli \| Badawi \| Fan	Young, Christina
89	Demographic associations with plasma biomarkers in the oldest-old: The LifeAfter90 Study	Young \| Colbeth \| Gilsanz \| Corrada \| Rizvi \| Zhou \| di Lucente \| DeCarli \| Jin \| Whitmer	Young, Christina
90	Differential sensitivity of T1-MRI and FDG-PET for tracking neurodegeneration across progressive stages of tau pathology in Alzheimer’s disease	Vourkas \| Karagianni \| Moscoso \| Zhang \| Sanchez-Juan \| Schöll \| Grothe \| Silva-Rodríguez	Silva-Rodríguez, Jesús
91	SPARE-Tau, a machine-learning derived tau-PET index, correlates with Alzheimer's disease and related dementias biomarkers	Wang \| Zeng \| Toledo \| Gonzales \| Honnorat \| Charisis \| Dong \| Ho \| Rashid \| Kutty \| Salman \| Vroman \| Seshadri \| Habes	Wang, David
92	Assessing the generalizability of plasma p-tau217 cutpoints for amyloid-β detection across clinical and preclinical cohorts	Liu \| Zeng \| Nafash \| Sehrawat \| Choity \| Gu \| Farinas \| Bedison \| Matan \| Gogola \| Huang \| Sewell \| McAuley \| Hillman \| Kramer \| Burns \| Kang \| Vidoni \| Nadkarni \| Aizenstein \| Kofler \| Tudorascu \| Shaaban \| Lingler \| Pascoal \| Villemagne \| Berman \| Sweet \| Snitz \| Ikonomovic \| Kamboh \| Erickson \| Cohen \| Lopez \| Deek \| Karikari	Liu, Tianshu
93	Evaluating the transferability of dual cutpoints for plasma p-tau217 in detecting brain amyloid-β across diverse cohorts	Liu \| Zeng \| Nafash \| Sehrawat \| Choity \| Gu \| Farinas \| Bedison \| Matan \| Gogola \| Huang \| Sewell \| McAuley \| Hillman \| Kramer \| Burns \| Kang \| Vidoni \| Nadkarni \| Aizenstein \| Kofler \| Tudorascu \| Shaaban \| Lingler \| Pascoal \| Villemagne \| Berman \| Sweet \| Snitz \| Ikonomovic \| Kamboh \| Erickson \| Cohen \| Lopez \| Deek \| Karikari	Liu, Tianshu
94	Free-water interacts with amyloid positivity to predict regional tau pathology in both early and late Braak stages	Sathe \| Durant \| Koran \| Dumitrescu \| Cody \| Sokołowski \| Kim \| Mez \| Saykin \| Toga \| Cuccaro \| Tosun \| Johnson \| Barber \| O'Bryant \| Landman \| Mormino \| Hohman \| Archer	Sathe, Aditi
95	Integration of data-driven biomarker discovery with established Alzheimer’s disease biomarkers in an African American cohort	Kuchenbecker \| Heckman \| Nguyen \| Casellas \| Sotelo \| Schwarz \| Senjem \| Jain \| Lucas \| Willis \| Ertekin-Taner \| Graff-Radford \| Kantarci \| Lowe \| Lachner \| Day \| Carrasquillo	Kuchenbecker, Lindsey
96	Early concordance between Aβ PET spatial extent and plasma %ptau217	Farrell \| Thibault \| Yang \| Price \| Chhatwal \| Coughlan \| Buckley \| Sperling \| Johnson	Farrell, Michelle

POSTER SESSIONS: 3A - Wednesday, January 14, 10:35 - 11:35 am; 3B - Wednesday, January 14, 2:45 - 3:45 pm

Board #	Title	Authors	Presenter
97	Longitudinal trajectories of plasma p-tau217 across multiple assays in relation to amyloid and tau PET and cognition	Shekari \| Tosun \| Dage \| Schindler \| Shaw \| Jagust \| Landau	Shekari, Mahnaz
98	The relation of psychosocial coping mechanisms to ATN pathophysiology differ across demographics.	Schatz \| Snitz \| Roush \| Lopresti \| Villemagne \| Lopez \| Williams \| Cohen	Williams, Lilcelia A.
99	Intermediate blood-based biomarker status clarified by PET and CSF in cognitively impaired individuals	Ziontz \| Blazhenets \| Lin \| Landau \| Shaw \| Dage \| Hammers \| Eloyan \| Koeppe \| Carillo \| Dickerson \| Rabinovici \| La Joie	Ziontz, Jacob
100	Operationalizing clinical criteria for LATE using cognitive, MRI, and AD biomarker (biofluid or PET) data	Cuppels \| Birkenbihl \| Schneider \| Bennett \| Brown \| Seto \| Coughlan \| Li \| Townsend \| Properzi \| James \| Arfanakis \| Sperling \| Yang \| Chhatwal \| Amariglio \| Hohman \| Donohue \| Buckley	Cuppels, Madison
101	CT-based processing is equivalent to MR-based processing for tau PET regional quantification	Povala \| Bellaver \| Amaral \| Lussier \| Ferreira \| Bauer-Negrini \| Tudorascu \| Masdeu \| Fortea \| Soleimani-Meigooni \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Povala, Guilherme
102	A pilot study on the association of plasma proteins with neuroimaging biomarkers of Alzheimer’s disease in African Americans	Arowolo \| Kuchenbecker \| Heckman \| Nguyen \| Casellas \| Sotelo \| Schwarz \| Senjem \| Jain \| Lucas \| Willis \| Ertekin-Taner \| Graff-Radford \| Kantarci \| Lowe \| Lachner \| Day \| Carrasquillo	Arowolo, Olatunbosun
103	Amyloid-PET and white matter hyperintensities but not military service duration nor combat exposure are associated with neurodegeneration and cognitive impairment in older veterans	Rocha \| Pasternak \| Lesman Segev \| Schwartz \| Blazhenets \| Maiti \| Rosen Lang \| Hantke \| Livny-Ezer \| Yaffe \| Shaw \| Weiner \| Hills \| Kritikos \| Soleimani-Meigooni \| Silbert \| La Joie \| Gardner	Rocha, Salma
104	The influence of cardiovascular risk on white matter integrity along the Alzheimer’s disease trajectory: Early impact in preclinical stages	Edison \| Arnold	Edison, Paul
105	Longitudinal tau PET progression follows language network spread in primary progressive aphasia	Martersteck \| Rogalski	Martersteck, Adam
106	The adjusted Centiloid: Improving reliability by correcting for white matter uptake variability	Reilhac \| Irizarry \| Reyderman \| Charil	Reilhac, Anthonin
107	Perivascular spaces: Predictors of longitudinal amyloid, tau, cerebrovascular biomarkers?	Low \| Gunter \| Hu \| Raghavan \| Przybelski \| Schwarz \| Kantarci \| Lowe \| Graff-Radford \| Petersen \| Jack \| Vemuri	Low, Audrey
108	Longitudinal evaluation of neuroinflammation using 11C-ER176 TSPO PET	Lim \| Cogswell \| Min \| Lee \| Brunn \| Kandimalla \| Jacobson \| Nycklemoe \| Lee \| Lundt \| Botha \| Graff-Radford \| Jones \| Vemuri \| Kantarci \| Jack \| Petersen \| Lowe	Lim, Seokbeen
109	Comparison of meningeal signal between [¹⁸F]AV-1451 and [¹⁸F]MK-6240 tau PET using a distance-based meningeal mask	Lim \| Gunter \| Baker \| Tissot \| Brunn \| Soleimani-Meigooni \| Oh \| Fortea \| Pascual \| Gordon \| Rosa-Neto \| Pascoal \| Klunk \| Jagust \| Senjem \| Botha \| Knopman \| McCarter \| Ramanan \| Graff-Radford \| Schwarz \| Kantarci \| Boeve \| Vemuri \| Jones \| Jack \| Petersen \| Lowe	Lim, Seokbeen
110	Effects of regional tau accumulation on visual discrimination of novel objects in clinically unimpaired older adults	Kapadia \| Medina Guerra \| Sai \| Bonnen \| Wagner \| Mormino \| Trelle	Kapadia, Dhruv
111	Key quantitative benchmarks with CenTauR in cross-sectional and longitudinal large datasets	Dore \| Bourgeat \| Betthauser \| Feizpour \| Moscoso \| Leuzy \| Fripp \| Johnson \| Rowe \| Villemagne	Dore, Vincent
112	Astrocytic reactivity is related to synchronization of regional amyloid-beta deposition	Adams \| Parker \| Taylor \| Tang \| Meza \| Tuteja \| Avila \| Chang \| Simmons \| Malhas \| Kim \| McMillan \| Mapstone \| Yassa	Adams, Jenna
113	Synergistic effects of amyloid-beta and hyperexcitability on tau pathology and cognitive decline	Vanderlip \| Adams	Adams, Jenna
114	Amyloid does not discriminate: a meta-analysis of sex differences in Centiloids from 35,468 participants across 33 cohorts	Blazhenets \| Pezzoli \| Casaletto \| Soleimani-Meigooni \| Chiotis \| Allen \| Rabinovici \| La Joie \| Study Group	Blazhenets, Ganna
115	Preliminary associations of plasma phosphorylated tau217 with regional tau deposition and accumulation in medial temporal and neocortical regions	Pintucci \| Thibault \| Farrell \| Yang \| Chhatwal \| Properzi \| Becker \| Price \| Sperling \| Johnson	Pintucci, Eva
116	Contrasting neuropathology- and tau PET-based Braak stage associations with dementia severity to clarify differences between radiologic and pathologic findings	Evelhoch \| Bruzzone \| Rocha \| Asthana \| Nirschl \| Johnson \| Schneider \| Hyman \| Pascoal \| Betthauser	Evelhoch, Jeffrey
117	Novel pet tracer [11C]-CS1P1 uptake reflects decreased sphingosine-1-phosphate receptor 1 activity in vivo in Alzheimer’s disease and related dementias	Tiemann Powles \| Friedrichsen \| Flores \| Rajamanickam \| Keefe \| Simmons \| Doering \| McKay \| Hoagey \| Sabaredzovic \| Ibanez \| Morris \| An \| Brier \| Tu \| Benzinger	Tiemann Powles, Savannah
118	Digital maze test reveals features related to cortical tau in cognitively normal Aβ+ older adults	Robinson \| Fu \| Amariglio \| Sperling \| Johnson \| Davis \| Penney \| Rentz	Robinson, Talia
119	Associations of regional neuroinflammation by ER176 PET SUVR with cognitive scores	Jacobson \| Lim \| Lundt \| Nycklemoe \| Min \| Botha \| Graff-Radford \| Jones \| Vemuri \| Kantarci \| Knopman \| Jack \| Petersen \| Lowe	Jacobson, David
120	Cluster-based metric of early tau-PET aggregation is associated with plasma p-tau217 in cognitively unimpaired older adults with subthreshold amyloid-beta	Varghese \| Brock \| Taylor \| Thomas \| Yassa \| Adams	Varghese, Leah
121	Sex differences in regional Aβ burden are associated with decreased cingulum integrity uniquely in older cognitively unimpaired women	Yi \| Parker \| Tang \| Taylor \| Tuteja \| Meza \| Avila \| Chang \| Simmons \| Bamford \| McMillan \| Kim \| Thomas \| Adams \| Yassa	Yi, Emily
122	Cerebral vessel morphology is associated with white matter lesions burden	Huang \| Li \| Rocha \| Stetten \| Yang \| Ibrahim \| Wu \| Aizenstein	Huang, Yuanzhe
123	Early ventral temporal tau burden marks functional vulnerability in aging	Sheng \| Trelle \| Sai \| Young \| Romero \| Park \| Vossler \| Younes \| Davidzon \| Wagner \| Mormino	Sheng, Jintao
124	Alignment of antemortem images to postmortem fixed hemibrains using standard neuroimaging tools	Coath \| Staruck \| Carey \| de Chavez \| Karas \| Abrahamson \| Asthana \| Johnson \| Ikonomovic \| Nirschl \| Betthauser	Coath, William
125	Towards a harmonized amyloid clock: centralized image processing and temporal modeling with multiple cohorts and tracers	Coath \| Bruzzone \| Morse \| Navaratna \| Hammond \| Staruck \| Nowinski \| Palmer \| Kelley \| Schwartz \| Carey \| Betthauser	Coath, William
126	Cluster-based MK-6240 PET detects early neocortical temporal tau spread	Thompson \| Becker \| Fanglu Fu \| Farrell \| Thibault \| Slade \| Sperling \| Price \| Johnson	Thompson, Jackson
127	Gaussian smoothing and partial volume correction modify relationships of tau burden with biological variables in longitudinal multi-site studies of 18F-Flortaucipir PET	Luo \| Laymon \| Baker \| Cohen \| Villemagne \| Lopresti \| Aizenstein \| Tudorascu \| Minhas	Luo, Weiquan
128	No detectable association between BDNF Val66Met and hippocampal volume or regional tau PET in ADNI after propensity score matching and ComBat harmonization	Han \| Minhas \| Laymon \| Villemagne \| Tudorascu	Han, Yushui
129	Centiloid and SUVR amyloid harmonization techniques comparisons for head-to-head unequally spaced data	Han \| Lopresti \| Bourgea \| Laymon \| Villemagne \| Tafti \| Minhas \| Tudorascu	Han, Yushui
130	Plasma amyloid beta 42/40 modifies the associations between MRI biomarkers and subsequent cognitive impairment: a neuroimaging-wide longitudinal study in the BLSA	Duran \| Bilgel \| An \| Kandala \| Davatzikos \| Landman \| Erus \| Ferrucci \| Moghekar \| Walker \| Resnick	Duran, Tugce
131	High-resolution NAV template using the Siemens Biograph Vision	Bourgeat \| Rowe \| Paranawithana \| Feizpour \| Huang \| Villemagne \| Fripp \| Dore	Rowe, Christopher
132	Higher clinical throughput quantitative amyloid-β PET using abbreviated acquisition windows	Paranawithana \| Gillman \| Bourgeat \| Fripp \| Villemagne \| O’Keefe \| Huang \| Benzinger \| LaMontagne \| Morris \| Doré \| Rowe	Rowe, Christopher C.
133	Tracer-specific effects of hormone replacement therapy on age-related tau accumulation	Tissot \| Shi \| Tsai \| Maboudian \| Fonseca \| Rahmouni \| Lussier \| Therriault \| Trudel \| Cassa Macedo \| Stevenson \| Bellaver \| Ferreira \| Povala \| Gordon \| Pascual \| Lowe \| Soleimani-Meigooni \| Oh \| Klunk \| Rosa-Neto \| Jagust \| Buckley \| Pascoal \| Baker	Tissot, Cécile
134	Cognitive and age-related differences in low-tau individuals assessed with [18F]FTP and [18F]MK6240	Tissot \| Shankar \| Tsai \| Rahmouni \| Lussier \| Therriault \| Trudel \| Cassa Macedo \| Stevenson \| Bellaver \| Ferreira \| Povala \| Gordon \| Pascual \| Lowe \| Soleimani-Meigooni \| Oh \| Klunk \| Rosa-Neto \| Jagust \| Landau \| Pascoal \| Baker	Tissot, Cécile
135	Integration of network analysis of the plasma proteome with Alzheimer's disease neuroimaging outcomes in an African American cohort	Hurst \| Kuchenbecker \| Heckman \| Nguyen \| Casellas \| Sotelo \| Shwarz \| Senjem \| Jain \| Lucas \| Willis \| Ertekin-Taner \| Graff-Radford \| Kantarci \| Lowe \| Lachner \| Day \| Carrasquillo	Hurst, Cheyenne
136	TSPO-mediated mitochondrial dynamics drive microglial activation in early Alzheimer’s disease: Implications for PET-based diagnosis	Lee \| Jung \| Lim \| Lowe	Jung, Dawa
137	MK6240 and Flortaucipir Braak staging agreement in a head-to-head cohort	Rocha \| Soares \| Ruppert \| Medeiros \| Bellaver \| Povala \| Ferreira \| Bauer-Negrini \| Lussier \| Tudorascu \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Pascoal, Tharick
138	Comparing neuropathologic and tau-PET Braak staging across clinical progression using MK6240 and flortaucipir	Rocha \| Bruzzone \| Ruppert \| Medeiros \| Soares \| Bellaver \| Povala \| Ferreira \| Lussier \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Johnson \| Evelhoch \| Betthauser \| Pascoal	Pascoal, Tharick
139	Predictors of data exclusion in MR-dependent imaging analyses of Alzheimer disease	Flores \| Scott \| Lu \| Su \| Keefe \| Smith \| Hornbeck \| McKay \| Strain \| Simmons \| Dombrowski \| Rizzo \| Shimony \| Bateman \| Babulal \| Landau \| Jagust \| Wolk \| Lah \| Gleason \| Johnson \| Roberson \| Sperling \| Johnson \| Morris \| Xiong \| Gordon \| Benzinger	Flores, Shaney
140	Brain network architecture shapes the pattern of tau-induced neuronal dysfunction in Alzheimer's disease, while tau load drives local damage	Frontzkowski \| Roemer-Cassiano \| Gnörich \| Dewenter \| Steward \| Zhu \| Klonowski \| Hirsch \| Biel \| Palleis \| Höglinger \| Brendel \| Franzmeier	Frontzkowski, Lukas
141	Cortical thickness and female sex confer resilience to tau-related cognitive decline: A large multi-cohort study	Mitchell	Mitchell, Stuart
142	Structure-guided design of 18F-FD4—a PET tracer of α-synuclein fibrils	Liu \| Li \| Wang \| Zuo \| Tan \| Bian \| Fan \| Liang	Qing, Liang
143	NULISAseq CNS proteomic signatures of astrocytic reactivity in Alzheimer’s disease	Shi \| Zeng \| Balogun \| Farinas \| Lopresti \| Gogola \| Ikonomovic \| Aizenstein \| Villemagne \| Cohen \| Karikari	Shi, Ruyu
144	High p-tau217 levels nullify the slower cognitive progression in younger older adults	Shi \| Choity \| Brodman \| Zeng \| Deek \| Gu \| Farinas \| Nafash \| Bedison \| Mercurio \| Matan \| Gogola \| Kofler \| Tudorascu \| Nadkarni \| Aizenstein \| Shaaban \| Lingler \| Pascoal \| Villemagne \| Berman \| Sweet \| Snitz \| Ikonomovic \| Cohen \| Kamboh \| Lopez \| Karikari	Shi, Ruyu

HAI Past Poster Sessions

Click on the sides of the image to “roll” the gallery.